Skip to main content
. Author manuscript; available in PMC: 2016 Mar 1.
Published in final edited form as: Bone Marrow Transplant. 2015 Jan 19;50(3):438–443. doi: 10.1038/bmt.2014.286

Table 2. Sirolimus Treatment.

Characteristics N (%)
Indication for voriconazole
 IFI Prophylaxis 61 (91)
 IFI prophylaxis in setting of GVHD 6 (9)
Day of voriconazole initiation (day, range) 8 (2-27)
Duration of coadministration, days (days, range) 113 (4-1342)
  0-100 days 43 (64)
  100-200 days 16 (24)
  200-300 days 6 (9)
  300-1000 days 1 (1)
  >1000 days 1 (1)
Concomitant tacrolimus administration 67 (100)